Literature DB >> 17591791

Comparative role of immunoglobulin A in protective immunity against the Bordetellae.

Daniel N Wolfe1, Girish S Kirimanjeswara, Elizabeth M Goebel, Eric T Harvill.   

Abstract

The genus Bordetella includes a group of closely related mammalian pathogens that cause a variety of respiratory diseases in a long list of animals (B. bronchiseptica) and whooping cough in humans (B. pertussis and B. parapertussis). While past research has examined how these pathogens are eliminated from the lower respiratory tract, the host factors that control and/or clear the bordetellae from the upper respiratory tract remain unclear. We hypothesized that immunoglobulin A (IgA), the predominant mucosal antibody isotype, would have a protective role against these mucosal pathogens. IgA(-/-) mice were indistinguishable from wild-type mice in their control and clearance of B. pertussis or B. parapertussis, suggesting that IgA is not crucial to immunity to these organisms. However, naïve and convalescent IgA(-/-) mice were defective in reducing the numbers of B. bronchiseptica in the upper respiratory tract compared to wild-type controls. Passively transferred serum from convalescent IgA(-/-) mice was not as effective as serum from convalescent wild-type mice in clearing this pathogen from the tracheae of naive recipient mice. IgA induced by B. bronchiseptica infection predominantly recognized lipopolysaccharide-containing O-antigen, and antibodies against O-antigen were important to bacterial clearance from the trachea. Since an IgA response contributes to the control of B. bronchiseptica infection of the upper respiratory tract, immunization strategies aimed at inducing B. bronchiseptica-specific IgA may be beneficial to preventing the spread of this bacterium among domestic animal populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591791      PMCID: PMC1951171          DOI: 10.1128/IAI.00412-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  Pertussis of adults and infants.

Authors:  C H Wirsing von König; S Halperin; M Riffelmann; N Guiso
Journal:  Lancet Infect Dis       Date:  2002-12       Impact factor: 25.071

Review 2.  The Fc receptor for IgA (FcalphaRI, CD89).

Authors:  Marielle A Otten; Marjolein van Egmond
Journal:  Immunol Lett       Date:  2004-03-29       Impact factor: 3.685

3.  Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Authors:  S M Hellwig; A B van Spriel; J F Schellekens; F R Mooi; J G van de Winkel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.

Authors:  Paul Mann; Elizabeth Goebel; James Barbarich; Mylisa Pilione; Mary Kennett; Eric Harvill
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

5.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

6.  Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

Authors:  H E de Melker; J F Schellekens; S E Neppelenbroek; F R Mooi; H C Rümke; M A Conyn-van Spaendonck
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

7.  Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.

Authors:  James D Cherry; Dorothy X L Xing; Penny Newland; Kashmira Patel; Ulrich Heininger; Michael J Corbel
Journal:  Clin Infect Dis       Date:  2004-01-29       Impact factor: 9.079

Review 8.  IgA Fc receptors.

Authors:  Renato C Monteiro; Jan G J Van De Winkel
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

9.  Role of antibodies in immunity to Bordetella infections.

Authors:  Girish S Kirimanjeswara; Paul B Mann; Eric T Harvill
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing.

Authors:  Ulrich Heininger; Peggy A Cotter; Howard W Fescemyer; Guillermo Martinez de Tejada; Ming H Yuk; Jeff F Miller; Eric T Harvill
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  17 in total

1.  Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Alexia T Karanikas; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

2.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

3.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

4.  The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.

Authors:  Xuqing Zhang; Elizabeth M Goebel; Maria Eugenia Rodríguez; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

5.  Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8.

Authors:  Xiaocong Yu; Mark Duval; Christopher Lewis; Melissa A Gawron; Rijian Wang; Marshall R Posner; Lisa A Cavacini
Journal:  J Immunol       Date:  2012-11-26       Impact factor: 5.422

6.  Serum IgA responses against pertussis proteins in infected and Dutch wP or aP vaccinated children: an additional role in pertussis diagnostics.

Authors:  Lotte H Hendrikx; Kemal Öztürk; Lia G H de Rond; Sabine C de Greeff; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

7.  Immune regulation of a chronic bacteria infection and consequences for pathogen transmission.

Authors:  Ashutosh K Pathak; Kathleen E Creppage; Jacob R Werner; Isabella M Cattadori
Journal:  BMC Microbiol       Date:  2010-08-25       Impact factor: 3.605

8.  Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.

Authors:  Elizabeth M Goebel; Xuqing Zhang; Eric T Harvill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

9.  Reduction of endotoxicity in Bordetella bronchiseptica by lipid A engineering: Characterization of lpxL1 and pagP mutants.

Authors:  Jesús Pérez-Ortega; Roel M Van Harten; Ria Van Boxtel; Michel Plisnier; Marc Louckx; Dominique Ingels; Henk P Haagsman; Jan Tommassen
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

10.  Lack of cross-protection against Bordetella holmesii after pertussis vaccination.

Authors:  Xuqing Zhang; Laura S Weyrich; Jennie S Lavine; Alexia T Karanikas; Eric T Harvill
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.